Quantitative Structure–Activity Relationship Models to Predict Cardiac Adverse Effects

Mou, Zhongyu; Volarath, Patra; Racz, Rebecca; Cross, Kevin P.; Girireddy, Mounika; Chakravarti, Suman; Stavitskaya, Lidiya

doi:10.1021/acs.chemrestox.4c00186

Title: Quantitative Structure–Activity Relationship Models to Predict Cardiac Adverse Effects

Journal Article · 13 November 2024 · Chemical Research in Toxicology

DOI: https://doi.org/10.1021/acs.chemrestox.4c00186 · OSTI ID:2481629

^[1]; Volarath, Patra ^[1]; Racz, Rebecca ^[1];

^[2]; Girireddy, Mounika ^[3]; Chakravarti, Suman ^[3];

^[1]

FDA Center for Drug Evaluation and Research (CDER), Silver Spring, Maryland 20903, United States
Instem, Columbus, Ohio 43215, United States
MultiCASE, Inc., Mayfield Heights, Ohio 44124, United States

Not Available

View Journal Article

Cite

Export

Save

Sponsoring Organization:: USDOE

OSTI ID:: 2481629

Journal Information:: Chemical Research in Toxicology, Journal Name: Chemical Research in Toxicology Journal Issue: 12 Vol. 37; ISSN 0893-228X

Publisher:: American Chemical SocietyCopyright Statement

Country of Publication:: United States

Language:: English

References (50)

Conventional and Atypical Antipsychotics and the Risk of Hospitalization for Ventricular Arrhythmias or Cardiac Arrest Liperoti, Rosa; Gambassi, Giovanni; Lapane, Kate L. Archives of Internal Medicine, Vol. 165, Issue 6 https://doi.org/10.1001/archinte.165.6.696	journal	March 2005
Postmarket Safety Events Among Novel Therapeutics Approved by the US Food and Drug Administration Between 2001 and 2010 Downing, Nicholas S.; Shah, Nilay D.; Aminawung, Jenerius A. JAMA, Vol. 317, Issue 18 https://doi.org/10.1001/jama.2017.5150	journal	May 2017
Bayesian pharmacovigilance signal detection methods revisited in a multiple comparison setting Ahmed, Ismaïl; Haramburu, Françoise; Fourrier‐Réglat, Annie Statistics in Medicine, Vol. 28, Issue 13 https://doi.org/10.1002/sim.3586	journal	April 2009
A phase 2 trial of verubulin for recurrent glioblastoma: a prospective study by the brain tumor investigational consortium (BTIC) Chamberlain, Marc C.; Grimm, Sean; Phuphanich, Surasak Journal of Neuro-Oncology, Vol. 118, Issue 2 https://doi.org/10.1007/s11060-014-1437-y	journal	April 2014
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development Redfern, W.; Carlsson, L.; Davis, A. Cardiovascular Research, Vol. 58, Issue 1 https://doi.org/10.1016/S0008-6363(02)00846-5	journal	April 2003
Drug-induced fibrotic valvular heart disease Bhattacharyya, Sanjeev; Schapira, Anthony H.; Mikhailidis, Dimitri P. The Lancet, Vol. 374, Issue 9689 https://doi.org/10.1016/S0140-6736(09)60252-X	journal	August 2009
DICTrank: The largest reference list of 1318 human drugs ranked by risk of drug-induced cardiotoxicity using FDA labeling Qu, Yanyan; Li, Ting; Liu, Zhichao Drug Discovery Today, Vol. 28, Issue 11 https://doi.org/10.1016/j.drudis.2023.103770	journal	November 2023
Drug-induced atrial fibrillation van der Hooft, Cornelis S.; Heeringa, Jan; van Herpen, Gerard Journal of the American College of Cardiology, Vol. 44, Issue 11 https://doi.org/10.1016/j.jacc.2004.08.053	journal	December 2004
Antipsychotic drugs and sudden cardiac death: A literature review of the challenges in the prediction, management, and future steps Zhu, Jingjing; Hou, Weihong; Xu, Yong Psychiatry Research, Vol. 281 https://doi.org/10.1016/j.psychres.2019.112598	journal	November 2019
Construction and analysis of a human hepatotoxicity database suitable for QSAR modeling using post-market safety data Zhu, Xiao; Kruhlak, Naomi L. Toxicology, Vol. 321 https://doi.org/10.1016/j.tox.2014.03.009	journal	July 2014
Toward a broader view of mechanisms of drug cardiotoxicity Mamoshina, Polina; Rodriguez, Blanca; Bueno-Orovio, Alfonso Cell Reports Medicine, Vol. 2, Issue 3 https://doi.org/10.1016/j.xcrm.2021.100216	journal	March 2021
Identification of structure–activity relationships for adverse effects of pharmaceuticals in humans: Part C: Use of QSAR and an expert system for the estimation of the mechanism of action of drug-induced hepatobiliary and urinary tract toxicities Matthews, Edwin J.; Kruhlak, Naomi L.; Daniel Benz, R. Regulatory Toxicology and Pharmacology, Vol. 54, Issue 1 https://doi.org/10.1016/j.yrtph.2009.01.007	journal	June 2009
Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part B. Use of (Q)SAR systems for early detection of drug-induced hepatobiliary and urinary tract toxicities Matthews, Edwin J.; Ursem, Carling J.; Kruhlak, Naomi L. Regulatory Toxicology and Pharmacology, Vol. 54, Issue 1 https://doi.org/10.1016/j.yrtph.2009.01.009	journal	June 2009
Prediction of drug-related cardiac adverse effects in humans-B: Use of QSAR programs for early detection of drug-induced cardiac toxicities Frid, Anna A.; Matthews, Edwin J. Regulatory Toxicology and Pharmacology, Vol. 56, Issue 3 https://doi.org/10.1016/j.yrtph.2009.11.005	journal	April 2010
Prediction of drug-related cardiac adverse effects in humans—A: Creation of a database of effects and identification of factors affecting their occurrence Matthews, Edwin J.; Frid, Anna A. Regulatory Toxicology and Pharmacology, Vol. 56, Issue 3 https://doi.org/10.1016/j.yrtph.2009.11.006	journal	April 2010
(Q)SAR assessments of potentially mutagenic impurities: A regulatory perspective on the utility of expert knowledge and data submission Powley, Mark W. Regulatory Toxicology and Pharmacology, Vol. 71, Issue 2 https://doi.org/10.1016/j.yrtph.2014.12.012	journal	March 2015
Assessing the impact of expert knowledge on ICH M7 (Q)SAR predictions. Is expert review still needed? Jayasekara, P. Suresh; Skanchy, Sophie K.; Kim, Marlene T. Regulatory Toxicology and Pharmacology, Vol. 125 https://doi.org/10.1016/j.yrtph.2021.105006	journal	October 2021
Predicting Cardiotoxicity of Molecules Using Attention-Based Graph Neural Networks Vinh, Tuan; Nguyen, Loc; Trinh, Quang H. Journal of Chemical Information and Modeling, Vol. 64, Issue 6 https://doi.org/10.1021/acs.jcim.3c01286	journal	March 2024
LeadScope ^† : Software for Exploring Large Sets of Screening Data Roberts, Gulsevin; Myatt, Glenn J.; Johnson, Wayne P. Journal of Chemical Information and Computer Sciences, Vol. 40, Issue 6 https://doi.org/10.1021/ci0000631	journal	November 2000
Optimizing Predictive Performance of CASE Ultra Expert System Models Using the Applicability Domains of Individual Toxicity Alerts Chakravarti, Suman K.; Saiakhov, Roustem D.; Klopman, Gilles Journal of Chemical Information and Modeling, Vol. 52, Issue 10 https://doi.org/10.1021/ci300111r	journal	September 2012
QSAR Modeling: Where Have You Been? Where Are You Going To? Cherkasov, Artem; Muratov, Eugene N.; Fourches, Denis Journal of Medicinal Chemistry, Vol. 57, Issue 12 https://doi.org/10.1021/jm4004285	journal	January 2014
Modeling Liver-Related Adverse Effects of Drugs Using k Nearest Neighbor Quantitative Structure−Activity Relationship Method Rodgers, Amie D.; Zhu, Hao; Fourches, Denis Chemical Research in Toxicology, Vol. 23, Issue 4 https://doi.org/10.1021/tx900451r	journal	March 2010
Describing the validity of carcinogen screening tests Cooper, J. A.; Saracci, R.; Cole, P. British Journal of Cancer, Vol. 39, Issue 1 https://doi.org/10.1038/bjc.1979.10	journal	January 1979
QSAR without borders Muratov, Eugene N.; Bajorath, Jürgen; Sheridan, Robert P. Chemical Society Reviews, Vol. 49, Issue 11 https://doi.org/10.1039/D0CS00098A	journal	January 2020
Drug‐Induced Torsades de Pointes and Implications for Drug Development Fenichel, Robert R.; Malik, Marek; Antzelevitch, Charles Journal of Cardiovascular Electrophysiology, Vol. 15, Issue 4 https://doi.org/10.1046/j.1540-8167.2004.03534.x	journal	April 2004
Risk of arrhythmia induced by psychotropic medications: a proposal for clinical management Fanoe, S.; Kristensen, D.; Fink-Jensen, A. European Heart Journal, Vol. 35, Issue 20 https://doi.org/10.1093/eurheartj/ehu100	journal	March 2014
Use of data mining at the Food and Drug Administration Duggirala, Hesha J.; Tonning, Joseph M.; Smith, Ella Journal of the American Medical Informatics Association, Vol. 23, Issue 2 https://doi.org/10.1093/jamia/ocv063	journal	July 2015
NCATS Inxight Drugs: a comprehensive and curated portal for translational research Siramshetty, Vishal B.; Grishagin, Ivan; Nguyễn, Ðắc-Trung Nucleic Acids Research, Vol. 50, Issue D1 https://doi.org/10.1093/nar/gkab918	journal	October 2021
DrugBank 5.0: a major update to the DrugBank database for 2018 Wishart, David S.; Feunang, Yannick D.; Guo, An C. Nucleic Acids Research, Vol. 46, Issue D1 https://doi.org/10.1093/nar/gkx1037	journal	November 2017
Physiological, pharmacological and toxicological considerations of drug‐induced structural cardiac injury Cross, M. J.; Berridge, B. R.; Clements, P. J. M. British Journal of Pharmacology, Vol. 172, Issue 4 https://doi.org/10.1111/bph.12979	journal	January 2015
Drug-Induced Long QT Syndrome Kannankeril, Prince; Roden, Dan M.; Darbar, Dawood Pharmacological Reviews, Vol. 62, Issue 4 https://doi.org/10.1124/pr.110.003723	journal	November 2010
Normalized names for clinical drugs: RxNorm at 6 years Nelson, Stuart J.; Zeng, Kelly; Kilbourne, John Journal of the American Medical Informatics Association, Vol. 18, Issue 4 https://doi.org/10.1136/amiajnl-2011-000116	journal	July 2011
Drug-induced valvular heart disease Cosyns, Bernard; Droogmans, Steven; Rosenhek, Raphael Heart, Vol. 99, Issue 1 https://doi.org/10.1136/heartjnl-2012-302239	journal	August 2012
A Phase I Study of Quisinostat (JNJ-26481585), an Oral Hydroxamate Histone Deacetylase Inhibitor with Evidence of Target Modulation and Antitumor Activity, in Patients with Advanced Solid Tumors Venugopal, Balaji; Baird, Richard; Kristeleit, Rebecca S. Clinical Cancer Research, Vol. 19, Issue 15 https://doi.org/10.1158/1078-0432.CCR-13-0312	journal	July 2013
Phase I Clinical Trial of MPC-6827 (Azixa), a Microtubule Destabilizing Agent, in Patients with Advanced Cancer Tsimberidou, Apostolia-Maria; Akerley, Wallace; Schabel, Matthias C. Molecular Cancer Therapeutics, Vol. 9, Issue 12 https://doi.org/10.1158/1535-7163.MCT-10-0516	journal	December 2010
Drugs That May Cause or Exacerbate Heart Failure Page, Robert L.; O’Bryant, Cindy L.; Cheng, Davy Circulation, Vol. 134, Issue 6 https://doi.org/10.1161/CIR.0000000000000426	journal	August 2016
Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association Tisdale, James E.; Chung, Mina K.; Campbell, Kristen B. Circulation, Vol. 142, Issue 15 https://doi.org/10.1161/CIR.0000000000000905	journal	October 2020
Improving the In Silico Assessment of Proarrhythmia Risk by Combining hERG (Human Ether-à-go-go-Related Gene) Channel–Drug Binding Kinetics and Multichannel Pharmacology Li, Zhihua; Dutta, Sara; Sheng, Jiansong Circulation: Arrhythmia and Electrophysiology, Vol. 10, Issue 2 https://doi.org/10.1161/CIRCEP.116.004628	journal	February 2017
Antipsychotic Drugs and the Risk of Ventricular Arrhythmia and/or Sudden Cardiac Death: A Nation‐wide Case‐Crossover Study Wu, Chi‐Shin; Tsai, Yu‐Ting; Tsai, Hui‐Ju Journal of the American Heart Association, Vol. 4, Issue 2 https://doi.org/10.1161/JAHA.114.001568	journal	January 2015
Drug-induced Valvulopathy: An Update Elangbam, Chandikumar S. Toxicologic Pathology, Vol. 38, Issue 6 https://doi.org/10.1177/0192623310378027	journal	August 2010
Pazopanib-induced fatal heart failure in a patient with unresectable soft tissue sarcoma and review of literature Karaağaç, Mustafa; Eryılmaz, Melek Karakurt Journal of Oncology Pharmacy Practice, Vol. 26, Issue 3 https://doi.org/10.1177/1078155219875797	journal	September 2019
Electrophysiological mechanisms of vandetanib-induced cardiotoxicity: Comparison of action potentials in rabbit Purkinje fibers and pluripotent stem cell-derived cardiomyocytes Lee, Hyang-Ae; Hyun, Sung-Ae; Byun, Byungjin PLOS ONE, Vol. 13, Issue 4 https://doi.org/10.1371/journal.pone.0195577	journal	April 2018
Drug-induced atrial fibrillation Tamargo, Juan; Caballero, Ricardo; Delpón, Eva Expert Opinion on Drug Safety, Vol. 11, Issue 4 https://doi.org/10.1517/14740338.2012.698609	journal	June 2012
The Medical Dictionary for Regulatory Activities (MedDRA) Brown, Elliot G.; Wood, Louise; Wood, Sue Drug Safety, Vol. 20, Issue 2 https://doi.org/10.2165/00002018-199920020-00002	journal	January 1999
Use of Screening Algorithms and Computer Systems to Efficiently Signal Higher-Than-Expected Combinations of Drugs and Events in the US FDA??s Spontaneous Reports Database Szarfman, Ana; Machado, Stella G.; O??Neill, Robert T. Drug Safety, Vol. 25, Issue 6 https://doi.org/10.2165/00002018-200225060-00001	journal	January 2002
Comparative Performance of Two Quantitative Safety Signalling Methods Almenoff, June S.; LaCroix, Karol K.; Yuen, Nancy A. Drug Safety, Vol. 29, Issue 10 https://doi.org/10.2165/00002018-200629100-00005	journal	January 2006
Drug-Induced Atrial Fibrillation Kaakeh, Yaman; Overholser, Brian R.; Lopshire, John C. Drugs, Vol. 72, Issue 12 https://doi.org/10.2165/11633140-000000000-00000	journal	August 2012
Martindale: The Complete Drug Reference. 37th ed Wisher, Doris Journal of the Medical Library Association : JMLA, Vol. 100, Issue 1 https://doi.org/10.3163/1536-5050.100.1.018	journal	January 2012
MedWatch: The FDA Safety Information and Adverse Event Reporting Program Craigle, Valeri Journal of the Medical Library Association, Vol. 95, Issue 2 https://doi.org/10.3163/1536-5050.95.2.224	journal	April 2007
Cardiovascular safety of antihistamines Olasińska-Wiśniewska, Anna; Olasiński, Jerzy; Grajek, Stefan Advances in Dermatology and Allergology, Vol. 3 https://doi.org/10.5114/pdia.2014.43191	journal	January 2014

Similar Records

Development of quantitative structure-activity relationship (QSAR) models to predict the carcinogenic potency of chemicals

Journal Article · 2009 · Toxicology and Applied Pharmacology · OSTI ID:21182707

Venkatapathy, Raghuraman; Chingyi, Wang; Bruce, Robert Mark; +1 more

Structure-activity relationships: quantitative techniques for predicting the behavior of chemicals in the ecosystem

Journal Article · 1988 · Environ. Sci. Technol.; (United States) · OSTI ID:6596852

Nirmalakhandan, N; Speece, R E

Computational approaches to understand the adverse drug effect on potassium, sodium and calcium channels for predicting TdP cardiac arrhythmias

Journal Article · 2017 · Journal of Molecular Graphics and Modelling · OSTI ID:1550414

Sharifi, Mohsen

Title: Quantitative Structure–Activity Relationship Models to Predict Cardiac Adverse Effects

Citation Formats

References (50)

Similar Records

Related Subjects